Of 1,486,984 new cancers registered in the Czech Cancer Registry in 1976-2005, 290,312 (19.5%) were multiple malignant neoplasms (MMNs), of which there were 65,292 primary and 89,796 subsequent cases in men and 59,970 primary and 75,254 subsequent cases in women. The duplicities were higher in women, and the triplicities and others (3-6 MMNs) were higher in men. The most frequent diagnoses were the primary cancers of skin, gastrointestinal and urinary tract, male genital organs, respiratory tract in men, and cancers of skin, breast, female genital organs, and gastrointestinal tract in women. The analysis of the early and advanced clinical stages shows that the number of subsequent advanced stages increased after primary advanced stages. Their time-age-space distributions visualized maps of MMNs in 14 Czech regions. These results support the improvement of algorithms of dispensary care for the early detection of the subsequent neoplasms.

Department of Science and Research University Hospital Brno Jihlavska 20 625 00 Brno Czech Republic

Zobrazit více v PubMed

IARC. Globocan. Lyon, France, IARC, 2008, http://globocan.iarc.fr/

IHIS. Cancer incidence in the Czech Republic. Health statistics, editorial series, http://www.uzis.com/

Twenty-five years of the Czech Association for combat and exploration of malignant tumors in Prague. Prague, Czech Republic, 1930.

Weiss J. Contribution to the statistics of the cancer increasing. Practical Medicine. 1933;22, article 617

Konečný M, Geryk E, Kubíček P, et al. Cancer Prevalence in the Czech Republic, 1989-2005-2015. Vol. 69. Brno, Czech Republic: Masaryk University; 2008.

Geryk E, Dítě P, Kozel J, et al. Cancer multiplicites in the Czech population. Casopís Lékařů Českých. 2010;149(4):178–183. PubMed

Geryk E, Bendová M, Kozel J. Breast cancer and subsequent primary malignant neoplasms in the Czech Republic 1976–2005. Oncology. 2009;3(1):54–61.

Geryk E, Dítě P, Sedláková L, et al. Trends of multiple non-melanoma skin cancers in a view of their epidemiology. Practice Dermatology. 2010;4(1 ):5–9.

Geryk E, Dítě P, Kozel J, et al. Other primary neoplasms in patients with prostate cancer in comparison of its incidence, mortality and prevalence. Oncology. 2010;4(2):89–93. PubMed

Dítě P, Geryk E. Trends of primary and subsequent cancers of the gastrointestinal tract in the czech population, 1976–2005. Digestive Diseases. 2010;28(4-5):657–669. PubMed

Geryk E, Kozel J, Štampach R, et al. Multiple cancers of nervous system and other primary neoplasms. Oncology. 2011;5(3):175–180.

Horvath T, Geryk E, Kozel J, et al. Lung cancer in multiple malignant neoplasms. Proceedings of the 3rd Lung Cancer Conference; 2012; Geneva, Switzerland.

Geryk E, Kozel J, Horváth T, et al. Patients with multiple cancers of head and neck. Oncology. 2012;6(5):260–265.

Geryk E, Kozel J, Pacík D, Štampach R, Horváth T. Multiple cancers of testis. Practice Urology. 2013;14(1):34–38.

Geryk E, Pacik D, Kozel J, et al. Penile cancers associated with occurrence of other neoplasms. Urology Letters. 2012;10(4):1–6.

Geryk E, Koška P, Dítě P, et al. Cancers, health and economy: parts of Pandoras box? Oncology. 2013;7(1):314–320.

Curtis RE, Freedman DM, Ron E, et al. New Malignancies Among Cancer Survivors: SEER Cancer Registries 1973–2000. Bethesda, Md, USA: National Cancer Institute; 2006.

ACS. Cancer Facts and Figures 2009. Atlanta, Ga, USA: American Cancer Society; 2009. Multiple primary cancers; pp. 24–41.

Billroth T, von Winiwarer A. Die Allgemeine Chirurgische Patologie Und Therapie. Berlin, Germany: G. Reimer; 1889.

Holland JM, Arsanjani A, Liem BJ, Christopher Hoffelt S, Cohen JI, Stevens KR. Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy. Journal of Laryngology and Otology. 2002;116(3):190–193. PubMed

Baxter NN, Tepper JE, Durham SB, Rothenberger DA, Virnig BA. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology. 2005;128(4):819–824. PubMed

Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. The Lancet. 2005;366(9503):2087–2106. PubMed

Rubino C, Shamsaldin A, Lê MG, et al. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Research and Treatment. 2005;89(3):277–288. PubMed

Valagussa P, Moliterni A, Terenziani M, Zambetti M, Bonadonna G. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Annals of Oncology. 1994;5(9):803–808. PubMed

Kaldor JM, Day NE, Kittelmann B, et al. Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. International Journal of Cancer. 1995;63(1):1–6. PubMed

Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. Journal of the National Cancer Institute. 2002;94(3):182–192. PubMed

Curtis RE, Freedman DM, Sherman ME, Fraumeni JF., Jr. Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer. Journal of the National Cancer Institute. 2004;96(1):70–74. PubMed

Swerdlow AJ, Jones ME, Brewster DH, et al. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Journal of the National Cancer Institute. 2005;97(5):375–384. PubMed

Fairley CK, Sheil AGR, McNeil JJ, et al. The risk of ano-genital malignancies in dialysis and transplant patients. Clinical Nephrology. 1994;41(2):101–105. PubMed

Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the nordic countries, 1964–1986. International Journal of Cancer. 1995;60(2):183–189. PubMed

Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. The New England Journal of Medicine. 1997;336(13):897–904. PubMed

Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. The New England Journal of Medicine. 2003;348(17):1681–1691. PubMed

Kirchhoff T, Kauff ND, Mitra N, et al. BRCA mutations and risk of prostate cancer in Ashkenazi jews. Clinical Cancer Research. 2004;10(9):2918–2921. PubMed

Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2005;143(5):326–379. PubMed

Ostfeld RS, Glass GE, Keesing F. Spatial epidemiology: an emerging (or re-emerging) discipline. Trends in Ecology and Evolution. 2005;20(6):328–336. PubMed

Konečný M, Reinhardt W. Early warning and disaster management: the importance of geographic information. International Journal of Digital Earth. 2010;3(3):217–220.

Štampach R, Konečný K, et al. Cartography in Central and Eastern Europe. Berlin, Germany: Springer; 2010. Dynamic cartographic methods for visualization of health statistics; pp. 431–442.